Figure 2

![Figure 2: Plasma zinc level distributions in males with androgenetic alopecia compared to controls, alongside treatment response correlation data, suggest that baseline zinc status may serve as a predictor of conservative therapy effectiveness in AGA management.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277952/bin/diagnostics-10-00336-g002.jpg)

> Source: Irina N Kondrakhina et al. "Plasma Zinc Levels in Males with Androgenetic Alopecia as Possible Predictors of." *Diagnostics (Basel, Switzerland)*, 2020. PMID: [32456296](https://pubmed.ncbi.nlm.nih.gov/32456296/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277952/bin/diagnostics-10-00336-g002.jpg" alt="Plasma zinc level distributions in males with androgenetic alopecia compared to controls, alongside treatment response correlation data, suggest that baseline zinc status may serve as a predictor of conservative therapy effectiveness in AGA management." />
  <figcaption>Figure 2. Plasma zinc level distributions in males with androgenetic alopecia compared to controls, alongside treatment response correlation data, suggest that baseline zinc status may serve as a predictor of conservative therapy effectiveness in AGA management.<br>  Source: Irina N Kondrakhina et al. "Plasma Zinc Levels in Males with Androgenetic Alopecia as Possible Predictors of." <em>Diagnostics (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32456296/">32456296</a></figcaption>
</figure>